Blog

  • IRS Ramps Up Penalties for Late Payroll Taxes – Clear Start Tax Shares What Employers Must Do Now

    IRS Ramps Up Penalties for Late Payroll Taxes – Clear Start Tax Shares What Employers Must Do Now

    Businesses face steeper fines in 2025 as the IRS cracks down on payroll tax compliance

    IRVINE, CALIFORNIA / ACCESS Newswire / October 1, 2025 / The IRS has announced tougher penalties for late payroll tax deposits in 2025, signaling a renewed focus on employer compliance. Payroll taxes – which fund Social Security, Medicare, and federal income tax withholdings – are among the most closely monitored obligations for businesses, and failing to pay them on time can result in significant financial consequences.

    “Payroll taxes are considered trust fund taxes, which means the IRS treats late or missing payments extremely seriously,” said a spokesperson for Clear Start Tax. “Employers who fall behind can face escalating penalties, interest, and even personal liability in some cases.”

    Clear Start Tax noted that businesses struggling with cash flow sometimes delay payroll deposits, but the IRS’s stepped-up enforcement leaves little room for error. “Even short delays can add up to major penalties,” the spokesperson explained. “Employers should prioritize payroll tax deposits above nearly every other business expense.”

    Experts advise business owners to set up automated deposit systems, track deadlines carefully, and consult tax professionals if they’ve already missed payments. With the IRS increasing penalties and enforcement resources, employers are urged to act quickly to avoid compounding costs.

    By answering a few simple questions, taxpayers can find out if they’re eligible for the IRS Fresh Start Program and take the first step toward resolving their tax debt.

    About Clear Start Tax
    Clear Start Tax is a national tax resolution firm dedicated to helping individuals and businesses manage IRS challenges. From payroll tax issues and audits to back taxes and debt relief programs, the firm provides tailored solutions that reduce risk and restore financial stability.

    Need Help With Back Taxes?

    Click the link below:
    https://clearstarttax.com/qualifytoday/
    (888) 710-3533

    Contact Information

    Clear Start Tax
    Corporate Communications Department
    tech@clearstarttax.com
    (949) 800-4011

    SOURCE: Clear Start Tax

    View the original press release on ACCESS Newswire

  • Liberty HealthShare Releases Comprehensive White Paper Marking 30 Years of Healthcare Sharing Ministry Innovation

    Liberty HealthShare Releases Comprehensive White Paper Marking 30 Years of Healthcare Sharing Ministry Innovation

    White Paper Documents 30-Year Journey from Church Aid Plan to National Ministry

    CANTON, OH / ACCESS Newswire / September 30, 2025 / Liberty HealthShare®, a leading healthcare sharing ministry, released a comprehensive white paper titled “Liberty HealthShare: Three Decades of Healthcare Sharing Ministry Innovation,” documenting the organization’s growth from a small church medical aid plan in rural Virginia to a nationally recognized ministry serving thousands of members.

    The 30th anniversary publication traces Liberty HealthShare’s origins to 1995, when five families from Gospel Light Mennonite Church created a simple solution to share medical expenses. Today, the ministry operates six medical cost-sharing programs plus dental sharing, maintains Charity Navigator’s highest four-star rating, and dedicates the majority of every dollar to member medical sharing.

    “God has certainly graced Liberty HealthShare with His blessings,” said Dorsey Morrow, Liberty HealthShare Chief Executive Officer. “He has presented us with some challenges over the years, but we continue to do His work by helping our members share the burdens of their fellow believers since 1995.”

    Key Achievements and Growth

    The white paper highlights significant milestones including federal recognition as an eligible healthcare sharing ministry in 2014, comprehensive program expansion serving demographics from young adults to Medicare-eligible seniors, and recent technological investments including the ShareBox portal and mobile application.

    Throughout 2025, Liberty HealthShare implemented multiple cost-reduction measures, with significant reductions in suggested monthly share amounts effective October 1-cuts of up to $26 per month on the ministry’s three most popular programs.

    The ministry has also expanded community impact through the Sharing Hearts Fund for Pediatric Wellness, established in early 2025. In July, the fund awarded grants totaling more than $17,000 to Stark County families for children’s medical needs including physical, dental, and vision care.

    Addressing Healthcare Cost Challenges

    The publication addresses Liberty HealthShare’s response to escalating healthcare costs, noting that national healthcare spending has grown from $1.4 trillion in 1995 to roughly $5 trillion today. Healthcare sharing ministry participation nationwide has expanded from approximately 150,000 members in 2010 to over 1.7 million Americans currently.

    “Throughout this year we will also be looking at, and praying about, what we can, and should, do to further strengthen this ministry and its position as the most comprehensive healthcare sharing ministry in America for the next 30 years,” Morrow stated.

    The white paper emphasizes Liberty HealthShare’s commitment to financial transparency, operational efficiency, and maintaining personal relationships that differentiate healthcare sharing from health insurance models.

    About Liberty HealthShare

    Liberty HealthShare is a non-profit 501(c) (3) charitable Christian medical cost-sharing ministry focused on members helping each other in times of need. The faith-based program facilitates healthsharing for its members in a caring community of health-conscious individuals and families who choose to support one another and agree to the Christian values of stewardship to make healthcare affordable for all.

    Liberty HealthShare is not an insurance company nor is it offered through an insurance company. Liberty HealthShare’s Sharing Programs do not guarantee or promise that a member’s medical bills will be paid or assigned to others for payment. Whether anyone chooses to pay a member’s medical bills will be totally voluntary. As such, Liberty HealthShare’s Sharing Programs should never be considered as a substitute for an insurance policy. Whether a member receives any payments for medical expenses and whether or not Liberty HealthShare continues to operate, the member is always liable for any unpaid bills.

    Media Contact:
    Keith Price
    Liberty HealthShare
    Phone: 855-585-4237
    Email: info@libertyhealthshare.org

    For more information about Liberty HealthShare, visit: www.libertyhealthshare.org

    The complete white paper “Liberty HealthShare: Three Decades of Healthcare Sharing Ministry Innovation” is available at https://www.libertyhealthshare.org/blog/liberty-healthshare-three-decades-of-healthcare-sharing-ministry-innovation.

    SOURCE: Liberty HealthShare

    View the original press release on ACCESS Newswire

  • One Water Global Launches Interlocking Bottle Technology at World Economic Forum

    One Water Global Launches Interlocking Bottle Technology at World Economic Forum

    EDMONTON, AB / ACCESS Newswire / September 30, 2025 / One Water, a premium bottled water company that aims to shake up the water bottle experience, has officially debuted its unique bottle technology at the World Economic Forum in Davos. The event took place January 21-23, 2025, allowing One Water to introduce its innovative product directly to thousands of global leaders and policymakers.

    This launch introduced attendees worldwide to One Water’s award-winning interlocking bottle technology and its flagship product, pure spring water sourced directly from the Canadian Rocky Mountains. Their mission is to promote sustainable practices while redefining a premium hydration experience. One Water’s presence at the World Economic Forum signals a significant shift in the industry as all eyes turn to more sustainable inventions.

    A Global Brand Built With Purpose

    One Water’s mission is to unite all of the world’s most pristine spring sources under one label, delivering a premium product while preserving the ecosystems from which it comes. The company wants people to see water as more than just a beverage; they should also recognize its origin, purity, and responsible sourcing.

    At Davos, the brand showcased its first launch from the Canadian Rockies, setting the stage for other sources like Italy, the Swiss Alps, and many more to come. Each source is carefully selected for quality and unique cultural identity, contributing to One Water’s mission.

    Unique Bottle Technology

    At the center of One Water’s launch was its patented interlocking bottle technology, a design that won the Best Innovative Technology Award at the Zenith Global Awards. The first-of-its-kind packaging system allows individual bottles to interlock with practical portability, storage, and transport advantages. The technology benefits both consumers and supply chain distributors.

    When no existing technology met One Water’s vision, the company decided to make its own. Their unique design demonstrates their commitment to premium products and to problem-solving with innovation. As a result, the packaging format reduces waste, is more efficient, and enhances the customer’s experience.

    Technological Innovation

    Since its inception, One Water has been built around its commitment to technological innovation. The interlocking design helps minimize packaging materials and carbon emissions that come from shipping by up to 35%.

    The brand’s sustainability strategy goes beyond packaging. One Water invests in ethical sourcing practices, ecosystem preservation, and long-term conservation efforts to protect its springs for future generations.

    One Water’s charity was set up to support and fund clean water projects in areas of extreme poverty. Every purchase of One Water helps bring clean water to communities that need access to safe water.

    About One Water Global

    One Water Global is a premium water brand from the world’s purest spring sources. Founded by Joelle El-Khatib, One Water created the first interlocking bottle technology with a mission to reshape how the world interacts with bottled water. They are purpose-driven by conservation, sustainability, efficiency, and cultural preservation, merging environmental responsibility with luxury hydration.

    To learn more, visit drinkonewater.com

    Media Contact:

    Joelle El-Khatib
    Joelle@drinkonewater.com
    drinkonewater.com

    SOURCE: One Water Global

    View the original press release on ACCESS Newswire

  • CMG Home Loans Announces the Opening of New Tacoma Central Branch

    CMG Home Loans Announces the Opening of New Tacoma Central Branch

    TACOMA, WA / ACCESS Newswire / September 30, 2025 / CMG Home Loans, the retail arm of the well-capitalized and privately held mortgage lender, CMG Financial, announced today the opening of a new branch in Tacoma, WA. Leading the Tacoma Central location is Area Sales Manager, Per Moerkeseth (NMLS ID# 518869), a veteran mortgage professional with nearly three decades of experience serving home buyers in the Puget Sound region.

    Moerkeseth began his career in 1998 through various roles at Bank of America, from Personal Banker to Banking Center Manager and later to Mortgage Branch Manager. He went on to serve as a Senior Loan Officer at Umpqua Bank and most recently as Branch Manager at HomeStreet Bank from 2014 to 2025. In addition to his lending experience, he has held leadership roles in the industry, serving as President of the Puget Sound Mortgage Lenders Association from 2010-2013 and acting as an Advisor/Investor for EG Business Metrics.

    “My team and I are so thrilled to be at CMG Home Loans and opening up a Tacoma location,” said Moerkeseth. “We searched companies to engage with and looked for culture, products, technology, and ways to best serve our customers and referral partners. CMG came out ahead in all categories. We are now all here officially, and the onboarding process has been absolutely incredible. From leadership to boots-on-the-ground teammates, we have been supported in all aspects. “

    “I’m truly excited to be working with Per again,” added Chad Jackson, Regional Sales Manager. “He has the leadership skills and experience we’ve been looking for to grow in the South Sound market. Even more importantly, he’s a perfect fit for our culture and brings a trusted reputation that will strengthen our entire team.”

    With the new Tacoma Central branch, CMG Home Loans continues to strengthen its presence across Washington while creating new opportunities for loan officers and real estate partners to grow alongside the company.

    If you’re interested in working with Per and his team or want to learn about other career opportunities at CMG, click here.

    About CMG Financial

    CMG Financial is a well-capitalized mortgage lender founded in 1993 by Christopher M. George, a former Mortgage Bankers Association Chairman. CMG makes its products and services available to the market through three distinct origination channels: retail lending, wholesale lending, and correspondent lending. CMG also operates seven joint venture companies with builder & realtor partners, holds an impressive MSR/servicing portfolio, and serves the capital markets of fixed income trading & sales through CMG Securities. CMG currently operates in all states, including District of Columbia, and holds approvals with FNMA, FHLMC, and GNMA. The company is consistently recognized as a top-producing lender and top mortgage employer, and it prides itself on helping clients achieve the dream of homeownership through product innovation and streamlined servicing.

    Contact Information

    Annaugh Madsen
    Senior Copywriter
    amadsen@cmgfi.com
    (667) 260-6360

    Alina Lundholm
    Junior Copywriter
    alundholm@cmgfi.com
    (847) 380-1954

    .

    SOURCE: CMG Financial

    View the original press release on ACCESS Newswire

  • From Vet Clinics to Store Shelves: Vetnique Accelerates Growth with Rapid Retail Expansion

    From Vet Clinics to Store Shelves: Vetnique Accelerates Growth with Rapid Retail Expansion

    Retail Expansion, New Product Innovation, and Triple-Digit Ecommerce Growth Drive Vetnique’s Ascent in Pet Health

    NAPERVILLE, IL / ACCESS Newswire / September 30, 2025 / Vetnique®, the vet-founded pet health company behind vet-formulated and vet-recommended solutions changing the lives of millions of pets, is experiencing record-setting growth and strategic expansion, solidifying its position as one of the fastest-growing companies in pet health.

    Maintaining a rapid pace of innovation throughout 2025, Vetnique released over 20 new products for cats and dogs into the market, designed to address everyday health needs across various categories such as gut health and digestion, hip and joint support, ear care, and more.

    As of August 2025, Vetnique’s vet-formulated and vet-recommended products, including supplements and topical solutions like wipes, sprays and ear flushes, are available in over 50,000 retail locations across the United States, including in retailers like Walmart, Tractor Supply Co., Petco, PetSmart, and Pet Supplies Plus.

    The marked growth in brick-and-mortar locations is highlighted by a significant expansion into Walmart store locations, where 11 of the brand’s core products-including Glandex®, YuMOVE®, and OticBliss®-are available across 3,563 stores, with additional product offerings on Walmart.com.

    Vetnique also debuted on Target.com in September 2025, further demonstrating the growing interest from mass retailers for accessible, science-backed, vet-recommended and vet-formulated pet health care solutions for consumers. Beyond its impressive retail presence, Vetnique’s e-commerce growth has also intensified with Amazon sales in North America increasing significantly, and Walmart sales surging with triple-digit growth as of August 2025.

    Dr. James Bascharon, DVM, Founder and CEO of Vetnique remarked, “These achievements reflect our unwavering commitment to improving pet health outcomes through science-backed solutions while building meaningful partnerships across veterinary and retail channels,” said Dr. Bascharon. “We do this for the pet parents who want the very best for their companions. It’s our mission to provide them with trusted, veterinarian-formulated solutions.”

    Driven by the Glandex Advanced Vet Strength formula, Vetnique’s multimodal approach to anal gland health is gaining traction in veterinary clinics nationwide, and with the 2024 acquisition of YuMOVE, the veterinarian exclusive of the efficacious hip and joint supplement has become a popular recommendation as well. With an increased sales team, an emphasis on new business development, and adding more distribution partners, Vetnique is sharpening its focus on the vet channel and the opportunities that exist for clinics nationwide to obtain access to vet-formulated products.

    Vetnique’s growth doesn’t stop there – it extends to its personnel, too, with the company more than doubling its head count in the last six months, exhibiting at major industry expos including VMX, Global Pet Expo, AVMA Convention, and SuperZoo, where they debuted the largest booth to date, and earning awards for innovative products such as “Dog Health Chews Product of the Year” at the 2025 Pet Innovation Awards.

    Vetnique is poised to continue to grow within the pet industry, which is projected to reach $350 billion globally by 2027.

    To learn more, please visit Vetnique.com.

    Media Contact

    Mike Wehner – Mike@NotablyPR.com

    About Vetnique

    Vetnique is a one-of-a-kind, global pet wellness company committed to helping your one-of-a-kind pets thrive with vet-recommended health care solutions. Founded by a veterinarian, supported by a team of passionate pet lovers, and recommended by over 100,000 veterinarians worldwide, Vetnique has evolved into one of the fastest growing, omnichannel pet brands in North America. Vetnique combines scientifically backed research with over a decade of experience to ensure every product is designed to meet the unique needs of pets. Uniquely Vet Founded, Vet Formulated, and Vet Recommended. Learn more about Vetnique at Vetnique.com.

    ####

    SOURCE: Vetnique

    View the original press release on ACCESS Newswire

  • U.S. Polo Assn. Delivers Elevated Americana With the 2025 Fall-Winter Global Collection From Denver, Colorado

    U.S. Polo Assn. Delivers Elevated Americana With the 2025 Fall-Winter Global Collection From Denver, Colorado

    Sport-Inspired Brand’s Seasonal Launch Includes 135th Anniversary Collection

    WEST PALM BEACH, FL / ACCESS Newswire / September 30, 2025 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), has launched its iconic, sport-inspired Fall-Winter Global Collection for 2025. This season’s release captures the brand’s classic Americana style and sporting heritage, set against the energetic spirit of Denver, Colorado, a city known for its dynamic mix of metropolitan culture and rugged natural beauty.

    From the heart of downtown Denver to the serene expanses of Aspen Ranch, these scenic landscapes provide the perfect backdrop for U.S. Polo Assn.’s 2025 Fall-Winter Global Collection. Reflecting a collegiate-inspired back-to-school theme, the seasonal campaign showcases the brand’s deep-rooted connection to sport, lifestyle, and fashion. The global photoshoot also features professional polo players Chloe Carabasi and Jake Klentner as models, further elevating the brand’s authentic connection to the sport of polo.

    “This year’s Fall-Winter Global Collection brings to life our global brand with classic, sporty, and elevated style, set in a location that reflects the youthful, vibrant energy of our consumer,” said J. Michael Prince, President and CEO of USPA Global, the company that manages and markets the global, multi-billion-dollar U.S. Polo Assn. brand. “Each seasonal collection U.S. Polo Assn. creates is a timeless celebration of sport and style, and this season is highlighted with the unique character of Denver, Colorado.”

    The U.S. Polo Assn. 2025 Fall-Winter Global Collection, photographed against the majestic Rocky Mountains, features a rich seasonal palette of Americana tones with a bold and fresh autumnal twist, alongside frosty holiday hues perfect for the cooler months. The Collection focuses on layered textures, thoughtful silhouettes, and timeless staples designed for a seamless transition from the classroom to the holidays, all in comfort and style. Standout pieces include U.S. Polo Assn.’s iconic polo shirts, rugged denim, cable-knit sweaters, flannel shirts, and varsity-inspired outerwear, with cozy holiday-ready layers and gifting-friendly options for the entire family.

    “This collection delivers a versatile wardrobe of polished yet practical pieces that bring together elevated everyday wear with a heritage-driven collegiate sensibility from U.S. Polo Assn.,” said Jessica Ramesberger, VP of Merchandising and Design at USPA Global. “Whether you’re dressing for back-to-school, a weekend getaway, or a holiday gathering, the U.S. Polo Assn. 2025 Fall-Winter Global Collection includes something stylish, comfortable, and accessible for everyone.”

    As part of its ongoing comprehensive USPA Life sustainability initiative, the brand incorporated USPA Life products throughout the 2025 Fall-Winter Global Collection. With preferred fabrics such as organic cotton woven throughout the Collection, U.S. Polo Assn. is committed to a path of continuous improvement, ensuring a positive impact on people, products, and the planet, thereby shaping a better future for the next generation. USPA Life is driving change in alignment with the Sustainable Development Goals, reflecting U.S. Polo Assn.’s commitment to meaningful impact.

    135th Anniversary Collection: Fall-Winter Edition

    U.S. Polo Assn. continues its 135th Anniversary celebration with select pieces in the 2025 Fall-Winter Global Collection that honor the brand’s legacy in the sport of polo and its roots dating back to 1890. This special capsule, distinguished by refined details and the brand’s signature red, white, and blue stripe, commemorates 135 years of sports inspiration and timeless fashion.

    “Denver’s energy and character mirrored the essence of U.S. Polo Assn.’s 2025 Fall-Winter Global Collection. From urban street style to rustic equestrian backdrops, this global photoshoot captures the diverse and dynamic lifestyles our brand celebrates,” said Stefanie Coroalles, VP of Global Marketing for USPA Global. “This season’s visuals tell a story of transition, tradition, and togetherness, everything Fall and Winter should feel like.”

    The 2025 Fall-Winter Global Collection is now available in U.S. Polo Assn. stores and online globally at uspoloassnglobal.com.

    About U.S. Polo Assn. and USPA Global

    U.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center (NPC) in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.

    U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world.

    For more information, visit uspoloassnglobal.com and follow @uspoloassn.

    USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.

    ###

    Contact Information

    Kaela Drake
    PR & Communications Specialist
    kdrake@uspagl.com
    +001.561.461.8596

    Stacey Kovalsky
    VP, Global PR and Communications
    skovalsky@uspagl.com
    +001.561.790.8036

    .

    SOURCE: U.S. Polo Assn.

    Related Images

    U.S. Polo Assn.'s 2025 Fall-Winter Global Collection
    U.S. Polo Assn.’s 2025 Fall-Winter Global Collection

    View the original press release on ACCESS Newswire

  • SMX Technology, Not Diplomacy, Is the Key to Ending a 30-Year Sustainability Debate Stalemate (NASDAQ:SMX)

    SMX Technology, Not Diplomacy, Is the Key to Ending a 30-Year Sustainability Debate Stalemate (NASDAQ:SMX)

    NEW YORK, NY / ACCESS Newswire / September 30, 2025 / COP 29 came and went like the 28 before it: speeches polished to perfection, headlines filled with urgency, and an outcome that changed almost nothing. Three decades of summits and still the world burns plastics instead of recycling them, still accepts fire-safety claims that collapse under pressure, and still mistakes diplomacy for progress.

    The UN Plastics Treaty conferences have followed the same pattern. Intent has never been the issue. Nations arrive with lofty goals, banners of ambition, and carefully worded declarations. But years of negotiations have delivered the same story arc: bold frameworks that wither under pressure, vague targets that slip quietly off the agenda, and another round of meetings scheduled to “finalize” what was supposed to be settled long ago. The intent deserves praise. The outcomes deserve scrutiny.

    That is why SMX (NASDAQ:SMX) matters. Where diplomacy has stalled, SMX brings enforcement at the molecular level. Its technology embeds proof directly into materials, transforming promises into verifiable results and making sustainability measurable, enforceable, and trusted across borders.

    The difference comes down to language. Diplomacy speaks in pledges, policies, and position papers. SMX speaks in proof. One can be debated. The other can be scanned. And in a world drowning in broken promises, only proof can cut through the noise.

    Diplomacy Requires A Universal Language of Proof
    The uncomfortable truth is this: diplomacy has had its chance. Nearly thirty years of it. The language has evolved, the communiqués have lengthened, and the photo ops have multiplied. However, emissions continue to rise, plastics accumulate, and real-world safety disasters persist, underscoring that promises are no substitute for proof.

    Diplomacy falters because consensus is fragile. Every nation arrives with different priorities, and every delegate guards their own interests; the result is watered-down targets that no one can measure or enforce. Policy by negotiation always collapses on contact with reality.

    Technology, by contrast, is universal. A molecular marker embedded into plastic in Singapore works the same way in Sweden, South Korea, or São Paulo. A scan confirming flame-retardant safety in Canada is identical to one in California. Proof doesn’t care about borders, politics, or bargaining positions. It is the one language every regulator, insurer, manufacturer, and consumer can understand.

    That’s why SMX’s system is so disruptive. It creates clarity where negotiation creates fog. Every recycled material, every under-the-radar plastic, every safety claim is no longer a matter of debate but a matter of fact.

    From Ballrooms to Factory Floors
    The futility of COP 29 and the UN Plastics Treaty wasn’t just their failure to achieve consensus; it was the spectacle of it all. Delegates fly in, luxury hotels are booked, gala dinners are staged – and then the same empty pledges are recycled alongside the plastics they never manage to regulate. The problem is not a lack of ambition; it is the absence of enforcement.

    SMX bypasses that cycle entirely. In Singapore, its work with A*STAR is turning national policy into an enforceable reality through a plastics passport platform. In Europe, its planned partnership with REDWAVE brings verification to the factory floor, where compliance is measured continuously in real-time. And in North America, with NAFRA, flame-retardant safety is finally shifting from datasheets to molecular scans.

    This is how change actually scales. Not through press releases at the close of conferences, but through tools embedded in production lines, products, and supply chains. Technology is enforcement. Enforcement is trust. And trust is the foundation of functioning markets.

    The End of Negotiated Sustainability
    The era of negotiated sustainability is over. It has been tried, and it has failed. What COP 29 and the UN Plastics Treaty proved, if nothing else, is that words alone cannot change the physics of plastics, the chemistry of fire, or the economics of waste. Those realities yield only to technology that works at the level where the problems exist: inside the materials themselves.

    SMX represents that shift. It isn’t another pledge, another target, or another diplomatic declaration. It is a platform where governments can regulate with certainty, industries can operate with confidence, insurers can price risk accurately, and consumers can trust the products in their hands.

    Diplomacy was supposed to deliver that. It never did. Technology just did.

    And history will not remember the meals in Paris, Geneva, or Dubai. It will remember the moment sustainability stopped being negotiated and started being proven – molecule by molecule.

    About SMX
    As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

    Forward-Looking Statements
    The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of gold, steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

    EMAIL: info@securitymattersltd.com

    SOURCE: SMX (Security Matters) Public Limited

    View the original press release on ACCESS Newswire

  • FDA-Authorized Expanded Access Programs Utilizing Jaguar Health’s Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease

    FDA-Authorized Expanded Access Programs Utilizing Jaguar Health’s Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease

    The two programs are being conducted under separate Single-Patient Investigational New Drug (sIND) applications in the United States

    SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family company Napo Pharmaceuticals (Napo) is providing the company’s novel crofelemer powder for oral solution for use in two expanded access programs, authorized by the U.S. Food and Drug Administration (FDA), to treat pediatric intestinal failure patients with microvillus inclusion disease (MVID).

    “Napo is committed to providing the novel crofelemer formulation as an investigational drug as deemed medically necessary by the physician caregiver for these two patients, intended for mitigating the sequela from MVID disease progression,” said Pravin Chaturvedi, PhD, Napo’s and Jaguar’s Chief Scientific Officer and Chair of the Scientific Advisory Board. “We wish both pediatric patients the best outcome and we are grateful to have this collaboration with the patients’ physician.”

    Jaguar, through Jaguar family companies Napo and Napo Therapeutics, is currently supporting two independent proof-of-concept investigator-initiated trials (IIT), and conducting two placebo-controlled clinical studies, of crofelemer in patients with intestinal failure due to the ultrarare disease MVID and the rare disease indication short bowel syndrome with intestinal failure (SBS-IF) in the United States, European Union, and/or Middle East/North Africa regions under appropriate regulatory approvals in each of these geographies.

    As announced, and as presented April 26, 2025 at the Annual ELITE PED-GI Congress, the initial proof-of-concept results of the ongoing IIT of a novel crofelemer powder formulation for oral solution in Abu Dhabi in the United Arab Emirates show that crofelemer reduced the required total parenteral nutrition (TPN) and supplementary intravenous fluids in the first participating MVID patient by up to 27% and in the first participating SBS-IF patient by up to 12.5%. An abstract describing the initial results of this trial has been accepted for presentation at the upcoming North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting taking place November 5-8, 2025 in Chicago.

    Additional proof-of-concept results from IITs of crofelemer for MVID and SBS-IF are expected later in 2025 and will provide additional preliminary data on the safety and potential effectiveness of crofelemer for these highly unmet clinical needs. Data from both above-referenced placebo-controlled clinical studies is expected in 2026.

    In accordance with the guidelines of specific European Union countries, published data from clinical investigations could support reimbursed early patient access to crofelemer for these debilitating conditions in 2026 while the company pursues approval of crofelemer for MVID and SBS-IF from the European Medicines Agency (EMA) and the FDA. Participation in early access programs, which do not exist in the U.S., provides an opportunity for reimbursement while impacting the morbidity and high cost of care for these chronic unmet needs. Additionally, the company expects that if even just a very small number of MVID patients show benefit with crofelemer, this may potentially allow expedited regulatory pathways in the U.S. and other regions, including qualifying crofelemer for participation in PRIME, an EMA program providing enhanced interaction and early dialogue with drug developers of novel medicines targeting unmet medical needs, and in the FDA’s Breakthrough Therapies program.

    Patients with MVID and SBS-IF suffer from devastating diarrhea and dehydration caused by these debilitating, lifelong conditions. These patients are frequently on TPN for as long as 20 hours a day, seven days a week – and TPN carries a significant risk of morbidity, infections, metabolic complications, liver and kidney problems, and neurodevelopmental delay. There are no approved drug treatments for MVID, an ultrarare pediatric disease with an estimated prevalence of about 200 patients worldwide. Short bowel syndrome (SBS) affects approximately 10,000 to 20,000 people in the U.S., according to the Crohn’s & Colitis Foundation, and it is estimated that the population of SBS patients in Europe is approximately the same size.

    About Crofelemer
    Crofelemer is a botanical (plant-based) drug extracted and purified from the red bark sap, also referred to as “dragon’s blood,” of the medicinal Croton lechleri tree in the Amazon Rainforest. Jaguar family company Napo Pharmaceuticals has established a sustainable harvesting program, under fair trade practices, for crofelemer to ensure a high degree of quality, ecological integrity, and support for indigenous communities.

    About the Jaguar Health Family of Companies
    Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar family company Napo Pharmaceuticals (Napo) focuses on developing and commercializing human prescription pharmaceuticals for essential supportive care and management of neglected gastrointestinal symptoms across multiple complicated disease states. Jaguar family company Napo Therapeutics is an Italian corporation Jaguar established in Milan, Italy in 2021 focused on expanding crofelemer access in Europe and specifically for orphan diseases.

    For more information about:
    Jaguar Health, visit https://jaguar.health
    Napo Pharmaceuticals, visit www.napopharma.com
    Napo Therapeutics, visit napotherapeutics.com

    Visit the Make Cancer Less Shitty patient advocacy program on Bluesky, X, Facebook & Instagram

    Forward-Looking Statements
    Certain statements in this press release constitute “forward-looking statements.” These include statements regarding Jaguar’s expectation that additional proof-of-concept results from IITs of crofelemer for MVID and SBS-IF will be available later in 2025 and will provide additional preliminary data on the safety and potential effectiveness of crofelemer for these highly unmet clinical needs, Jaguar’s expectation that data from both above-referenced placebo-controlled clinical studies will be available in 2026, Jaguar’s expectation that, in accordance with the guidelines of specific EU countries, published data from clinical investigations could support reimbursed early patient access to crofelemer for MVID and SBS-IF in 2026 while the company pursues approval of crofelemer for MVID and SBS-IF from the EMA and the FDA, and Jaguar’s expectation that, if even just a very small number of MVID patients show benefit with crofelemer, this may potentially allow expedited regulatory pathways in the U.S. and other regions, including qualifying crofelemer for participation in the EMA’s PRIME program and the FDA’s Breakthrough Therapies program. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “aim,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to a number of risks, uncertainties and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar’s control. Except as required by applicable law, Jaguar does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

    CONTACT:
    hello@jaguar.health
    Jaguar-JAGX

    SOURCE: Jaguar Health, Inc.

    View the original press release on ACCESS Newswire

  • Switchboard Health Acquires Conduce Health, Expanding AI-Enabled Specialty Care Capabilities

    Switchboard Health Acquires Conduce Health, Expanding AI-Enabled Specialty Care Capabilities

    Acquisition advances value-based specialty care delivery by bringing predictive AI and precision patient-specialist matching into Switchboard’s specialty care platform

    BOISE, ID AND NEW YORK CITY, NY / ACCESS Newswire / September 30, 2025 / Switchboard Health, creators of a digital health platform connecting patients with high-value specialty care, today announced the acquisition of Conduce Health, an AI-driven solution for personalized multispecialty care. The acquisition will combine Switchboard’s EMR-integrated software and virtual care network with Conduce’s predictive analytics and clinical decision support technology to match patients with the best-fit specialists.

    Founded in 2023 by an experienced team of health tech entrepreneurs and physicians and backed by AlleyCorp, Conduce developed an AI platform that makes specialty care proactive, predictive, and personalized. Its software empowers clinical teams to refer patients to optimal specialists based on nuanced clinical and personal variables.

    Through this acquisition, Switchboard Health will integrate Conduce’s advanced AI capabilities – including predictive models for disease progression, urgent medical needs, and precision patient-specialist matching – into its referral management, care navigation, and virtual care capabilities. These enhancements will enable Switchboard’s provider and health plan clients to even more effectively connect patients to high-value specialists. Key Conduce team members will also join Switchboard.

    “This acquisition squarely fits our mission to transform specialty care,” said Derek Baird, CEO and co-founder of Switchboard Health. “The AI capabilities, expertise, and talent from Conduce will accelerate our progress in administering value-based specialty care models.”

    “We founded Conduce to ensure patients receive personalized, multispecialty care the first time, every time,” said Najib Jai, MD, co-founder and CEO of Conduce Health. “We’re excited to see Switchboard integrate Conduce’s technology into its referral and care navigation workflows to advance that mission and deliver high-value specialty care at scale.”

    “We have always believed Conduce’s AI-first approach could dramatically improve specialty care delivery,” said Jeff De Flavio, MD, Conduce Board Chair and AlleyCorp Entrepreneur in Residence. “We look forward to seeing the outcomes from pairing Conduce technology and key team members with Switchboard’s platform, value-based specialty care frameworks, and growing client base.”

    About Switchboard Health
    Switchboard Health helps providers, health plans, and employers deliver high-value specialty care services. Our software platform and national specialty care network deliver improved access, reduced costs, and much-needed support to patients seeking care. For more information, visit www.switchboardhealth.com

    About Conduce Health
    Conduce provides AI-powered tools risk bearing entities, hospital systems, and payers need to deliver value-based specialty care. Our novel approach incentivizes value-based alignment, facilitates care coordination, and ensures timely access to high-quality personalized, and affordable specialty care. Learn more at www.conducehealth.com.

    MEDIA CONTACT:

    Jessica Cohen
    Aria Marketing for Switchboard Health
    jcohen@ariamarketing.com
    617.785.9579

    SOURCE: Switchboard Health

    View the original press release on ACCESS Newswire

  • Avel eCare Recognized as a Top Telemedicine Service by Healthcare Business Review

    Avel eCare Recognized as a Top Telemedicine Service by Healthcare Business Review

    SIOUX FALLS, SD / ACCESS Newswire / September 30, 2025 / Avel eCare has been named among the Top Telemedicine Services of 2025 by Healthcare Business Review. The recognition highlights Avel’s role in setting a new standard for virtual, system-wide care, expanding access to high-quality healthcare in rural, urban, and underserved communities nationwide.

    According to Healthcare Business Review, companies chosen for this prestigious list have “demonstrated outstanding capabilities in their respective industries, earning their place at the top. Renowned for their cutting-edge solutions, services, and exceptional customer support, they stand out in their fields after receiving numerous nominations. A panel of C-level executives, industry experts, and our editorial board conducted a comprehensive evaluation to select the top companies.”

    With more than 30 years of telemedicine leadership, Avel eCare delivers an integrated system of care that spans emergency, behavioral health, hospitalist, pharmacy, specialty clinic, ICU, and more. By connecting hospitals, clinics, schools, EMS providers, and long-term care facilities to a team of board-certified physicians, nurses, and specialists, Avel provides reliable care that improves outcomes, reduces unnecessary transfers, and strengthens local health systems.

    “This recognition reflects the tireless dedication of our team and our partners nationwide,” said Doug Duskin, CEO of Avel eCare. “From critical access hospitals to large health systems, our mission has always been the same: to ensure that every patient, no matter their location, has timely access to the highest level of care. Being honored as a top telemedicine service validates that vision.”

    Avel eCare’s innovative approach has been proven to:

    • Improve quality metrics such as reduced ICU length of stay and faster emergency department throughput

    • Provide financial value by alleviating staffing shortages and reducing reliance on costly locum coverage

    • Strengthen recruitment and retention by supporting bedside teams with 24/7 expertise

    As demand for telehealth accelerates-with the global telehealth market projected to reach $1.18 trillion by 2032 according to BioSpace.com (https://www.biospace.com/telehealth-market-poised-to-surge-usd-1-186-59-billion-by-2032)- Avel continues to lead the way with scalable, reliable solutions that bring stability and innovation to healthcare delivery.

    About Avel eCare
    Avel eCare is a national leader in technology-enabled clinical services delivered through telemedicine, offering provider-to-provider virtual care solutions that expand clinical capacity and improve outcomes across the healthcare industry. With more than 30 years of innovation, Avel’s board-certified clinicians partner with hospitals, clinics, long-term care facilities, schools, EMS agencies, and correctional health systems nationwide to bring high-quality care to patients when and where it’s needed most. Learn more at: www.avelecare.com

    Media Contact:
    Jessica Gaikowski
    Avel eCare
    media@avelecare.com

    SOURCE: Avel eCare

    View the original press release on ACCESS Newswire